Pharmacotherapy

Expert Q&A

Pharmacotherapy for Autism Spectrum Disorder

Topics: Aripiprazole | Autism | Bumetanide | complementary medicine | Lurasidone | Pharmacotherapy | Risperidone | Supplements

CCPR: Welcome, Dr. Krause. Tell us a little bit about the recent paper you coauthored called Pharmacologic Management of Autism Spectrum Disorder: A Review of Seven Studies (Kothadia RJ et al, Current Psychiatry 2021;20(1):33–38). Dr. Krause: Our study was a review of reviews. The aim was to see if we could find any new insights into medication treat

Read More
Clinical Update

Pharmacotherapy for Stimulant Use Disorders

Topics: medications | Pharmacotherapy | Stimulants

Stimulant use is surprisingly common. In 2017, 5.5 million people in the US took cocaine, and 757,000 of these people used crack. Another 5.1 million people misused prescription stimulants, representing nearly 2% of the total population (SAMHSA, 2019; www.samhsa.gov/data/). Many pharmacological trials for stimulant use disorder have been conducted, but

Read More
Expert Q&A

Diagnosing and Treating Stimulant Use Disorders

Topics: contingency management | Diagnosis | Harm reduction | online therapy | Pharmacotherapy | Psychotherapy | Stimulants

CATR: Welcome, Dr. dela Cruz. Tell us what you do. Dr. dela Cruz: I’m an assistant professor at UT Southwestern Medical School where I’m the adult psychiatry residency associate program director, and I teach medical students, residents, and fellows. Clinically, I’m an outpatient addiction psychiatrist where I treat a variety of patients with subs

Read More